Tamoxifen for breast cancer prevention: safety warning.
Eric
E
Wooltorton
D016588:Anticarcinogenic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008403:Mass Screening; D018579:Patient Selection; D011322:Primary Prevention / Q000379:methods; D011655:Pulmonary Embolism / Q000139:chemically induced; D018570:Risk Assessment; D012307:Risk Factors; D012449:Safety; D020521:Stroke / Q000139:chemically induced; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000139:chemically induced
D016588:Anticarcinogenic Agents; D013629:Tamoxifen